These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 21928275
1. HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. Su Z, Sun C, Zhou C, Liu Y, Zhu H, Sandoghchian S, Zheng D, Peng T, Zhang Y, Jiao Z, Wang S, Xu H. Eur J Immunol; 2011 Dec; 41(12):3586-95. PubMed ID: 21928275 [Abstract] [Full Text] [Related]
5. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis. Yamashita T, Iwakura T, Matsui K, Kawaguchi H, Obana M, Hayama A, Maeda M, Izumi Y, Komuro I, Ohsugi Y, Fujimoto M, Naka T, Kishimoto T, Nakayama H, Fujio Y. Cardiovasc Res; 2011 Sep 01; 91(4):640-8. PubMed ID: 21622681 [Abstract] [Full Text] [Related]
6. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response. Yan L, Hu F, Yan X, Wei Y, Ma W, Wang Y, Lu S, Wang Z. J Mol Med (Berl); 2016 Sep 01; 94(9):1063-79. PubMed ID: 27052830 [Abstract] [Full Text] [Related]
7. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U. J Exp Med; 2006 Aug 07; 203(8):2009-19. PubMed ID: 16880257 [Abstract] [Full Text] [Related]
8. HMGB1 Facilitated Macrophage Reprogramming towards a Proinflammatory M1-like Phenotype in Experimental Autoimmune Myocarditis Development. Su Z, Zhang P, Yu Y, Lu H, Liu Y, Ni P, Su X, Wang D, Liu Y, Wang J, Shen H, Xu W, Xu H. Sci Rep; 2016 Feb 22; 6():21884. PubMed ID: 26899795 [Abstract] [Full Text] [Related]
9. Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy. Nindl V, Maier R, Ratering D, De Giuli R, Züst R, Thiel V, Scandella E, Di Padova F, Kopf M, Rudin M, Rülicke T, Ludewig B. Eur J Immunol; 2012 Sep 22; 42(9):2311-21. PubMed ID: 22730043 [Abstract] [Full Text] [Related]
10. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Göser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, Katus HA, Kaya Z. Circulation; 2005 Nov 29; 112(22):3400-7. PubMed ID: 16316965 [Abstract] [Full Text] [Related]
11. Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Tajiri K, Shimojo N, Sakai S, Machino-Ohtsuka T, Imanaka-Yoshida K, Hiroe M, Tsujimura Y, Kimura T, Sato A, Yasutomi Y, Aonuma K. Cardiovasc Drugs Ther; 2013 Oct 29; 27(5):413-24. PubMed ID: 23722419 [Abstract] [Full Text] [Related]
12. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Liu W, Nakamura H, Shioji K, Tanito M, Oka S, Ahsan MK, Son A, Ishii Y, Kishimoto C, Yodoi J. Circulation; 2004 Sep 07; 110(10):1276-83. PubMed ID: 15337697 [Abstract] [Full Text] [Related]
13. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis. Cruz-Adalia A, Jiménez-Borreguero LJ, Ramírez-Huesca M, Chico-Calero I, Barreiro O, López-Conesa E, Fresno M, Sánchez-Madrid F, Martín P. Circulation; 2010 Oct 05; 122(14):1396-404. PubMed ID: 20855659 [Abstract] [Full Text] [Related]
14. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. Matsui Y, Okamoto H, Jia N, Akino M, Uede T, Kitabatake A, Nishihira J. J Mol Cell Cardiol; 2004 Aug 05; 37(2):557-66. PubMed ID: 15276025 [Abstract] [Full Text] [Related]
15. Hydrodynamics-based delivery of an interleukin-1 receptor II fusion gene ameliorates rat autoimmune myocarditis by inhibiting IL-1 and Th17 cell polarization. Chang H, Wang Y, Wu W, Li G, Hanawa H, Zou J. Int J Mol Med; 2013 Apr 05; 31(4):833-40. PubMed ID: 23403812 [Abstract] [Full Text] [Related]
16. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. Liu W, Li WM, Gao C, Sun NL. J Autoimmun; 2005 Dec 05; 25(4):258-63. PubMed ID: 16242301 [Abstract] [Full Text] [Related]
17. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis. Lee JH, Kim TH, Park HE, Lee EG, Jung NC, Song JY, Seo HG, Seung KB, Chang K, Lim DS. Cardiovasc Res; 2014 Feb 01; 101(2):203-10. PubMed ID: 24189626 [Abstract] [Full Text] [Related]
18. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease. Martín R, Cordova C, San Román JA, Gutierrez B, Cachofeiro V, Nieto ML. J Mol Cell Cardiol; 2014 Jul 01; 72():250-62. PubMed ID: 24732212 [Abstract] [Full Text] [Related]
19. [The protective role of interleukin-6 monoclonal antibody on experimental autoimmune myocarditis and its mechanism]. He S, Han LN, Wang YT, Liu JW, Ding GL. Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Mar 01; 30(2):119-23. PubMed ID: 25016860 [Abstract] [Full Text] [Related]
20. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis. Chang H, Zhao F, Xie X, Liao Y, Song Y, Liu C, Wu Y, Wang Y, Liu D, Wang Y, Zou J, Qi Z. Exp Cell Res; 2019 Feb 01; 375(1):22-30. PubMed ID: 30557558 [Abstract] [Full Text] [Related] Page: [Next] [New Search]